Abstract |
Clinically approved small-molecule magnetic resonance imaging (MRI) contrast agents are all rapidly cleared from the body and offer weak signal enhancement. To avoid repeated administration of contrast agent and improve signal-to-noise ratios, agents with stronger signal enhancement and better retention in tumors are needed. Therefore, we focused on hydrogels because of their excellent water accessibility and biodegradability. Gadolinium (Gd)-chelating cross-linkers were incorporated into self-assembled pullulan nanogels to both impart magnetic properties and to stabilize this material that has been extensively studied for medical applications. We show that these Gd-chelating pullulan nanogels (Gd-CHPOA) have the highest reported relaxivity for any hydrogel-based particles and accumulate in the 4T1 tumors in mice at high levels 4 h after injection. This combination offers high signal enhancement and lasts up to 7 days to delineate the tumor clearly for longer imaging time scales. Importantly, this long-term accumulation does not cause any damage or toxicity in major organs up to three months after injection. Our work highlights the clinical potential of Gd-CHPOA as a tumor-imaging MRI contrast agent, permitting tumor identification and assessment with a high signal-to-background ratio.
|
Authors | Minnie Chan, Jacques Lux, Tomoki Nishimura, Kazunari Akiyoshi, Adah Almutairi |
Journal | Biomacromolecules
(Biomacromolecules)
Vol. 16
Issue 9
Pg. 2964-71
(Sep 14 2015)
ISSN: 1526-4602 [Electronic] United States |
PMID | 26278775
(Publication Type: Journal Article, Research Support, N.I.H., Extramural)
|
Chemical References |
- Contrast Media
- Polysaccharides
- Gadolinium
|
Topics |
- Animals
- Contrast Media
(chemistry, pharmacology)
- Gadolinium
(chemistry, pharmacology)
- Magnetic Resonance Imaging
- Mice
- Mice, Inbred BALB C
- Nanoparticles
(chemistry)
- Neoplasms, Experimental
(diagnostic imaging)
- Polysaccharides
(chemistry, pharmacology)
- Radiography
|